Articles by J.M. Liddell, PhD - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by J.M. Liddell, PhD

J.M. Liddell, PhD


J.M.Liddell, PhD, is head of process science at Avecia Biologics Ltd.

Production Strategies for Antibody Fragment Therapeutics
June 2, 2009

Microbial systems such as E. Coli and yeasts are most effective for producing antibody fragments.

ADVERTISEMENT

ADVERTISEMENT

Click here